Clinical Analysis of Immunodeficiency-Associated Lymphoproliferative Disorders in a Single Institution
Conclusions: Overall survival of immunodeficiency-associated lymphoproliferative disorders under recent immunosuppressive settings, especially PTLD, was still poor. We found that low number of lymphocyte count could be a new risk factor for poor prognosis, along with known factors as IPI and hypoalbuminemia. Low IgG value was also suggested to be a prognostic factor for inferior outcome in PTLD patients.Figure.DisclosuresNishikori: Eisai: Research Funding; Ono Pharmaceuticals: Research Funding.
Source: Blood - Category: Hematology Authors: Watanabe, M., Kanda, J., Arai, Y., Nishikori, M., Hishizawa, M., Kondo, T., Yamashita, K., Takaori, A. K. Tags: 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Retrospective/Observational Studies Source Type: research
More News: Allergy & Immunology | Arthritis | Burkitt Lymphoma | Chemotherapy | Hodgkin's Disease | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Lung Transplant | Lupus | Lymphoma | Methotrexate | Radiation Therapy | Rheumatoid Arthritis | Rheumatology | Scleroderma | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants | Urology & Nephrology